Decoding SCAD: New Insights into Spontaneous Coronary Artery Dissection
"A large-scale study reveals critical risk factors and potential preventative measures for this underdiagnosed heart condition."
Spontaneous Coronary Artery Dissection (SCAD) is a heart condition that occurs when a tear forms in a coronary artery. This tear can slow or block blood flow to the heart, leading to a heart attack, arrhythmia, or sudden death. Unlike heart attacks caused by plaque buildup (atherosclerosis), SCAD often affects younger, otherwise healthy individuals, and it's more prevalent in women.
For years, SCAD was underdiagnosed. However, increased awareness and improved diagnostic techniques have led to a surge in reported cases. This has allowed researchers to delve deeper into understanding the condition, its causes, and how to manage it effectively. A groundbreaking study published in the Journal of the American College of Cardiology sheds new light on SCAD, offering valuable insights into long-term outcomes and risk factors for recurrence.
This article breaks down the key findings of this important study, translating complex medical information into practical knowledge for those at risk, those diagnosed with SCAD, and anyone interested in protecting their heart health. We'll explore the identified risk factors, potential preventative measures, and the importance of ongoing research in this evolving field.
What We Know About SCAD
Recognition and diagnosis of spontaneous coronary artery dissection (SCAD) have advanced markedly over the past decade. Even so, the basic mechanisms of the disease, its contributing factors, and its treatment remain poorly understood. A contemporary review also identifies SCAD as a subject of current diagnosis and treatment review, without providing additional statistics in the available source material.
Why SCAD Needs a Distinct Approach
SCAD is a distinct cause of acute coronary syndromes, and its optimal management differs from management of atherosclerotic ACS. Identifying SCAD matters because the diagnosis has specific long-term prognostic and therapeutic implications. SCAD involves separation of the coronary artery wall layers and can cause myocardial infarction without obstructive coronary artery disease. Despite advances in recognition and diagnosis, its mechanisms, contributing factors, and treatment remain poorly understood.
What the Latest Research Reveals About SCAD
Researchers prospectively followed 327 SCAD patients at Vancouver General Hospital, gathering comprehensive data on their medical history, risk factors, triggers, angiographic features, treatments, and cardiovascular events. The study aimed to identify predictors of recurrent SCAD and evaluate the effectiveness of different treatment strategies.
- Who is Affected: The average age of SCAD patients was 52.5 years, with a significant majority (90.5%) being women. Over half of the women were postmenopausal.
- How SCAD Presents: All patients experienced a myocardial infarction (MI), with varying types of ECG changes.
- Potential Triggers: Emotional stressors were reported by 48.3% of patients, while physical stressors were reported by 28.1%.
- Underlying Conditions: Fibromuscular dysplasia (FMD), a condition affecting the arteries, was present in 62.7% of patients. Other conditions like connective tissue disorders and systemic inflammatory diseases were also noted.
- Treatment Approaches: Most patients (83.1%) were initially treated with medication. A smaller percentage required percutaneous coronary intervention (PCI) or coronary artery bypass graft surgery (CABG).
- Long-Term Outcomes: Over a median follow-up of 3.1 years, 19.9% of patients experienced a major adverse cardiac event (MACE), including death, recurrent MI, stroke/TIA, or revascularization. Recurrent SCAD occurred in 10.4% of patients.
Research Is Expanding Across Key Areas
A May 10, 2024 review describes SCAD as an important cause of acute coronary syndromes, with higher incidence among younger female patients. A review published May 7, 2026, summarizes advances in understanding, diagnosis, and management, and reports that SCAD results from an intramural hematoma or related arterial-wall injury. A September 9, 2026 review surveys recent work on SCAD pathogenesis, pathophysiology, epidemiology, clinical diagnosis, treatment strategies, and long-term management. Another source dated the same day reports that SCAD accounts for 1% to 4% of acute coronary syndrome cases and that 90% of affected patients are women.
Intervention Has Important Limits
A 2025 review reports that SCAD lesions often heal spontaneously over time, while their anatomical and pathophysiologic features are associated with high failure rates for percutaneous coronary intervention. SCAD itself involves a non-atherosclerotic, non-traumatic, non-iatrogenic tear or intramural hematoma in the coronary artery wall, which can form a false lumen and obstruct blood flow. A case-series source describes SCAD as an increasingly recognized cause of acute coronary syndrome, myocardial infarction, and sudden death, especially among young women, while noting a lack of further detail in the provided excerpt.
Management Choices Remain Unsettled
SCAD is described as an underdiagnosed cause of acute coronary syndrome that usually presents in young female patients. The best management approach remains unsettled: a 2025 report states there is no clear consensus and sets out to compare conservative treatment with an invasive approach. A 2021 systematic review likewise says ideal SCAD management has not been clearly defined and describes a search of studies published from database inception through September 2020. The available source excerpts do not provide comparative efficacy or safety results, so they do not establish which approach is superior.
Protecting Your Heart: What You Can Do
This research underscores the importance of understanding SCAD, particularly for women. While more research is needed, here are some potential takeaways for protecting your heart health: <ul><li><b>Manage Blood Pressure:</b> If you have hypertension, work closely with your doctor to manage it effectively.</li><li><b>Discuss Beta-Blockers:</b> Talk to your doctor about whether beta-blocker therapy is appropriate for you, especially if you have SCAD or risk factors.</li><li><b>Minimize Stress:</b> Identify and manage emotional and physical stressors in your life. Explore stress-reduction techniques like mindfulness, yoga, or spending time in nature.</li><li><b>Know Your Risks:</b> Be aware of the potential risk factors for SCAD, such as FMD and family history.</li></ul>SCAD is a complex condition, and ongoing research is crucial for developing better diagnostic and treatment strategies. Stay informed, advocate for your health, and work with your healthcare team to create a personalized plan for a healthy heart.
Greater Recognition, Continuing Questions
A 2018 review describes SCAD as an emerging cause of acute coronary syndrome, particularly in young females, and says heightened awareness and new diagnostic tools—especially intracoronary imaging—suggest it is more prevalent than previously thought. A 2024 contemporary review similarly notes that SCAD is increasingly recognized as a cause of myocardial infarction, most frequently affecting younger women. It points to the evolution of intracoronary imaging, improved diagnosis with coronary angiography, and ongoing research attention as part of that changing picture. Together, the sources describe growing recognition while emphasizing the importance of continued clinical and research attention.
Evidence Gaps in Long-Term Care
A contemporary review says knowledge of SCAD has expanded over the past two decades, but evidence to guide management after an event and prevention of future adverse events remains limited. This leaves important questions about how best to support patients beyond the acute episode. The available source identifies post-event management and prevention as areas where stronger evidence is needed.
Recognition and Care in Practice
A 2024 case report describes SCAD as an uncommon cause of acute coronary syndrome that may be overlooked in young women presenting with ACS symptoms, with adverse outcomes possible when it is missed. The report emphasizes timely diagnosis and management and details a case involving a middle-aged woman. Separately, a study across three tertiary hospitals in Western Australia investigated SCAD characteristics, management practices, and short-term outcomes among women. Its source notes a paucity of high-level evidence to guide management decisions.